Nephrology Center, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Chin J Integr Med. 2013 Feb;19(2):86-91. doi: 10.1007/s11655-013-1351-8. Epub 2013 Jan 31.
Chronic kidney disease (CKD) has become a worldwide health and social problem. Retarding its progression to end-stage renal disease is beneficial both to the patients and the healthcare system. Plenty of clinical trials have indicated that enema with Chinese medicine could effectively prevent chronic renal failure, and was widely used in the clinical practice. However, studies on mechanism were still nearly blank, which may prevent further improvement of therapeutic efficacy. Recent studies had discovered that colon was an important organ where uremic toxins were generated. The uremic toxins involved could not only promote CKD progression, but also was closely correlated with CKD mortality. Reducing production and promoting excretion of toxins were confirmed to reduce renal tubule interstitial fibrosis and delay renal progression. On the basis of the theory of gut-kidney axis above, we had conducted pilot clinical researches to evaluate the effect of enema with Chinese medicine on the intestinal flora, gut barrier, enterogenous uremic toxins and renal protection. The preliminary results revealed that rheum enema through colon could accelerate intestinal dynamics, improve intestinal barrier function, regulate intestinal flora and reduce production and absorption of intestine-derived uremic toxins such as indoxyl sulfate, which may reduce renal fibrosis and delay renal progression. Further studies could provide more evidence for colon as a new therapeutic target for the treatment of CKD with Chinese medicine.
慢性肾脏病(CKD)已成为全球性的健康和社会问题。延缓其向终末期肾病进展,对患者和医疗保健系统都有益处。大量临床试验表明,中药灌肠可有效预防慢性肾衰竭,并在临床实践中广泛应用。然而,关于其作用机制的研究仍几乎空白,这可能会阻碍进一步提高治疗效果。最近的研究发现,结肠是产生尿毒症毒素的重要器官。这些尿毒症毒素不仅可以促进 CKD 的进展,而且与 CKD 的死亡率密切相关。减少毒素的生成和促进其排泄被证实可以减少肾小管间质纤维化并延缓肾脏进展。基于肠-肾轴理论,我们已经开展了初步的临床研究,以评估中药灌肠对肠道菌群、肠屏障、肠源性尿毒症毒素和肾脏保护的影响。初步结果表明,大黄灌肠可通过结肠促进肠道动力,改善肠屏障功能,调节肠道菌群,减少吲哚硫酸酯等肠源性尿毒症毒素的生成和吸收,从而可能减少肾脏纤维化并延缓肾脏进展。进一步的研究可为中药治疗 CKD 以结肠为新的治疗靶点提供更多证据。